Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02304575
Other study ID # 0482-14-RMC
Secondary ID
Status Recruiting
Phase N/A
First received November 27, 2014
Last updated October 15, 2017
Start date January 2015
Est. completion date November 2018

Study information

Verified date October 2017
Source Rabin Medical Center
Contact David Margel, MD PhD
Phone +972(0)39378089
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Testicular Cancer is the most prevalent malignancy among men between 20 and 34 years of age, with incidence rates rising in western countries including Israel. Cure rate of testicular cancer exceeds 90% with modern treatments. Thus issues such as quality of life (QoL), coping, effects on couple relationships, cognitive function, cognitive orientation and hormonal function become increasingly important. This study aims to assess all these issues using validated, reproducible questionnaires and hormonal plasma levels, and compare them between testicular cancer survivors and controls.


Description:

The study will be conducted in RMC, Beilinson and Golda. Eligible male patient list will be drawn from the Rabin Medical Center (RMC) operation rooms' data system.

Patients will be contacted by their treating urologists over the phone or during follow-up visits and invited to take part in the research which will be conducted at RMC. The first stage of the study will include a validation of the EORTC QLQ-TC26 questionnaire in Hebrew.

Patients and partners / spouses will sign informed-consent forms and fill out questionnaires during their visit, and blood samples will be drawn on the day of questionnaire completion or no longer than 1 month from it. Spouses will be given the choice of arriving with the patient and filling-in their questionnaires at RMC, or having them mailed to their homes. Research assistants will provide assistance with the questionnaires.

Normal controls will be recruited among Tel Aviv University students, 'Achva' College students and RMS staff and asked to come to RMC for blood tests. Control subjects will be asked to answer the same cancer-related questionnaires as the patients, as fully as possible, unless the questions are irrelevant to them.

The anticipated recruitment period will be approximately 36 months. Financial incentives: a compensation of 150 NIS will be offered to healthy participants coming to RMC for blood tests under this study.

Duration of research participation: 1 or 2 encounters (the second for missing data or missing blood samples, and in the first 30 patients - for TC26 questionnaire re-validation by the EORTC requirements), during no longer than 1 month for each participant.

Measurements will be compared across the patient and 2 control groups and their correlation to hormonal function assessed.


Recruitment information / eligibility

Status Recruiting
Enrollment 330
Est. completion date November 2018
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

Group1: Testicular cancer long-term survivors

- Male subjects between 2 to 10 years after testicular cancer diagnosis, who have completed treatment and are regarded as complete responders.

- Able to give informed consent Group 2: Benign testicular conditions patients

- Male subjects between 2 to 10 years after testicular surgery due to a benign condition.

- Able to give informed consent Group 3: Healthy Controls

- Healthy males

- Able to give informed consent Partners of males from above 3 groups

- Females or males

- In a couple relationship with a man of 1 of the above groups, for 1 year or longer.

- Able to give informed consent

Exclusion criteria:

Group1: Testicular cancer long-term survivors

- Inability to answer questionnaires (i.e due to mental impairment).

- Another malignancy, other than non-invasive skin basal cell carcinoma (BCC) or squamous cell carcinoma (SCC).

- Testicular cancer recurrence. Group 2: Benign testicular conditions patients

- Inability to answer questionnaires.

- Any history of malignancy other than non-invasive skin BCC or SCC. Group 3: Healthy Controls

- Inability to answer questionnaires.

- Any history of malignancy other than non-invasive skin BCC or SCC.

- Any history of testicular surgery or diagnosed testicular problems in adulthood or childhood.

Partners of males from above 3 groups

- Inability to answer questionnaires.

Study Design


Intervention

Other:
Questionnaires
Questionnaires: For examinee: European Organization for Research and Treatment of Cancer quality of life questionnaire of 30 items and testicular cancer module of 26 items (EORTC QLQ-30 + QLQ-TC-26), Multidimensional Coping Inventory, The Meaning Test for cognitive function, cognitive orientation questionnaires. For partner: Multidimensional Inventory of quality of life (QoL) for Adults, Multidimensional Coping Inventory.
Hormonal Function measurement
Plasma levels of: follicular stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), prolactin, free androgen index.

Locations

Country Name City State
Israel Rabin Medical Center, Beilinson & Hasharon Hospitals Petah Tikva

Sponsors (1)

Lead Sponsor Collaborator
Rabin Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life (QLQ), as measured by the QLQ-TC26 (Testicular Cancer 26 items) questionnaire. 2-10 years from diagnosis
Secondary Hormonal function, as measured by follicular stimulating hormone (FSH) & free androgen index 2-10 years from diagnosis
Secondary cognitive orientation score 2-10 years from diagnosis
Secondary multidimensional coping score 2-10 years from diagnosis
Secondary cognitive function as measured by the meaning test 2-10 years from diagnosis
Secondary Partner's Quality of life, as measured by the multidimensional inventory of QOL for adults questionnaire 2-10 years from diagnosis
Secondary Partner's Coping mechanism score, as measured by the Multidimensional Coping Inventory 2-10 years from diagnosis
See also
  Status Clinical Trial Phase
Completed NCT00639899 - The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy N/A
Not yet recruiting NCT03281915 - the Effect of Different Modialites of Varicocelectomy on Semen Parameters in Patient With Normal Semen Analysis N/A
Recruiting NCT03540056 - Testicular Growth During Puberty in Boys With and Without a Left-sided Varicocele
Completed NCT02983656 - Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine N/A
Enrolling by invitation NCT05617261 - Evaluating Patient Tolerability and Success for Penile and Scrotal Urologic Procedures Under Conscious Sedation: A Prospective Study
Not yet recruiting NCT05330533 - Effect of Recent Ejaculation on Scrotal Duplex Parameters in Infertile Males With Varicocele
Not yet recruiting NCT03090438 - IVF Outcomes After Varicocele Repair N/A
Completed NCT02401087 - The Anaesthesiological Approach to Varicocele Correction in Outpatients Setting: an Observational Analysis
Completed NCT00044369 - Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele N/A
Completed NCT05034406 - The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain N/A
Completed NCT03477149 - EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications N/A
Not yet recruiting NCT05171504 - Lactoferrin and Iron in Seminal Plasma of Varicocele
Completed NCT02335385 - Single Incision Laparoscopic Varicocelectomy N/A
Not yet recruiting NCT03341897 - Varicocele Treatement by Endovasculer Embolization N/A
Active, not recruiting NCT03079609 - The Search for Viral and Bacterial Etiology of Varicocele N/A
Not yet recruiting NCT02719093 - Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery Phase 4
Enrolling by invitation NCT02033863 - Evaluation of PerformanCe of the Peripheral EOS in the Treatment of Varicocele or Pelvic Congestion SynDromE N/A
Recruiting NCT02695199 - Doppler Ultrasound Assisted Varicocelectomy Improve Sperm Qualities N/A
Completed NCT01463787 - Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial Phase 4
Completed NCT01259258 - Dye Assisted Lymphatic Sparing Subinguinal Varicocelectomy Phase 2